Joachim Burman

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

Claire Bridel, Wessel N. van Wieringen, Henrik Zetterberg et al. · JAMA Neurology · 2019 · 760 citations · Full text

Life Sciences, Neurology, Neuroscience +14

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Gustavo Luna, Peter Alping, Joachim Burman et al. · JAMA Neurology · 2019 · 509 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +10

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery

Moa Fransson, Elena Piras, Joachim Burman et al. · Journal of Neuroinflammation · 2012 · 352 citations · Full text

Life Sciences, Immunology, Neuroscience +17

Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis

Richard K. Burt, Roumen Balabanov, Joachim Burman et al. · JAMA · 2019 · 300 citations · Full text

Medicine, Neurology, Cell Therapy +14

Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)

Basil Sharrack, Riccardo Saccardi, Tobias Alexander et al. · Bone Marrow Transplantation · 2019 · 245 citations · Full text

Life Sciences, Immunology, Neurology +15